de Simone G - Search Results

1

Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network).

Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, De Luca N, Trimarco B, de Simone G. Gerdts E, et al. Among authors: de luca n, de simone g. Int J Cardiol. 2018 May 1;258:257-261. doi: 10.1016/j.ijcard.2017.12.086. Int J Cardiol. 2018. PMID: 29544940 Free article.

2

Left ventricular hypertrophy in hypertension as a predictor of coronary events: relation to geometry.

de Simone G, Palmieri V. de Simone G, et al. Curr Opin Nephrol Hypertens. 2002 Mar;11(2):215-20. doi: 10.1097/00041552-200203000-00013. Curr Opin Nephrol Hypertens. 2002. PMID: 11856915 Review.

3

Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study.

de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. de Simone G, et al. Hypertension. 2002 Oct;40(4):470-6. doi: 10.1161/01.hyp.0000034740.99323.8a. Hypertension. 2002. PMID: 12364349 Clinical Trial.

4

Quantitation of left ventricular mass and function: balancing evidence with dreams.

de Simone G, Galderisi M. de Simone G, et al. Ital Heart J. 2002 Oct;3(10):562-70. Ital Heart J. 2002. PMID: 12478813 Review.

5

Gender differences in left ventricular chamber and midwall systolic function in normotensive and hypertensive adults.

Celentano A, Palmieri V, Arezzi E, Mureddu GF, Sabatella M, Di Minno G, De Simone G. Celentano A, et al. Among authors: de simone g. J Hypertens. 2003 Jul;21(7):1415-23. doi: 10.1097/00004872-200307000-00033. J Hypertens. 2003. PMID: 12817192

6

Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective.

de Simone G. de Simone G. J Am Soc Nephrol. 2003 Oct;14(10):2421-7. doi: 10.1097/01.asn.0000088724.66957.fc. J Am Soc Nephrol. 2003. PMID: 14514719 Review.

7

Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass.

Galderisi M, de Simone G, Cicala S, De Simone L, D'Errico A, Caso P, de Divitiis O. Galderisi M, et al. Among authors: de divitiis o, de simone g, de simone l. J Hypertens. 2003 Nov;21(11):2183-8. doi: 10.1097/00004872-200311000-00029. J Hypertens. 2003. PMID: 14597863

8

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.

de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlöf B, de Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB. de Simone G, et al. Among authors: de faire u. Circulation. 2005 Apr 19;111(15):1924-31. doi: 10.1161/01.CIR.0000161799.91577.0A. Circulation. 2005. PMID: 15837945 Clinical Trial.

9

Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study.

de Simone G, Devereux RB, Maggioni AP, Gorini M, de Divitiis O, Verdecchia P; MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group. de Simone G, et al. Among authors: de divitiis o. Am J Hypertens. 2005 Oct;18(10):1288-93. doi: 10.1016/j.amjhyper.2005.05.027. Am J Hypertens. 2005. PMID: 16202850

10

Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study.

Narayan P, Papademetriou V, Wachtell K, Gerdts E, Boman K, Nieminen MS, de Simone G, Dahlöf B, Fyhrquist F, Hoieggen A, Devereux RB. Narayan P, et al. Among authors: de simone g. Hypertension. 2006 May;47(5):868-73. doi: 10.1161/01.HYP.0000215578.40687.6f. Epub 2006 Mar 27. Hypertension. 2006. PMID: 16567586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

923 results

Search Page

Filters